FDA approves first gene therapy for genetic hearing loss

NBC News·Apr 23

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

The FDA has approved a gene therapy for genetic hearing loss, which is the first of its kind. The therapy, developed by Regeneron, has been shown to restore hearing in children with a rare condition. The approval is seen as a significant development, with some outlets describing it as "groundbreaking" and marking a new era in treatment for inherited deafness.

Full coverage

FDA Approves First-Ever Gene Therapy For Deafness, Opening Door To New Era

Forbes·May 19

FDA approves first gene therapy for inherited deafness, shown to restore hearing for children with rare condition

CNN·Apr 23

Regeneron's Gene Therapy For Genetic Hearing Loss Gets Accelerated FDA Nod — Drug Pricing Deal With White House To Be Announced Today

Stocktwits·1d ago

Regeneron wins FDA approval for first gene therapy for genetic hearing loss

Reuters·Apr 23

WTAS: FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss Under National Priority Voucher Program

HHS.gov·Apr 28

Fetching the latest headlines…